Case T-278/22 R: Order of the President of the General Court of 4 August 2022 — Biogen Netherlands v Commission (Interim relief — Medicinal products for human use — Regulation (EC) No 726/2004 — Marketing authorisation for Dimethyl fumarate Neuraxpharm — dimethyl fumarate — Application for suspension of operation of a measure — No urgency)
Maintenance EN
Please note that this website will be undergoing technical maintenance between 28 and 31 August. Consequently, users may experience instabilities and limited functionality. We apologise for the inconvenience.
Web Content Display (Global)
Publication Detail Actions Portlet
Publication Detail Portlet

Publication detail

Pop up window annotations
Publication Viewer

Document viewer